Bawang, Aya Azkiyyah B.

HRN: 23-76-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/12/2024
08/19/2024
IV
300mg
IV
PCAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: